Search Results

Keywords: "United Kingdom"

First commercial export of nonpsychoactive cannabis from Colombia reaches UK

Bogota-based Clever Leaves announced that the first Colombian shipment of nonpsychoactive cannabis products for commercial sale reached London’s Heathrow Airport on July 27, and the health-related goods cleared customs Wednesday. The products, which were exported as a food supplement, will soon be available for sale in the United Kingdom and other European Union countries, according to […]

Read More

Craft Cannabis: Infusing Methods

As marijuana cultivators work to define “craft cannabis,” makers of infused products are trying to do the same—and explain to consumers why (in some cases) they should be willing to pay more for such items. What defines cannabis-infused craft products depends on whom you ask. For some, it means using sun-grown cannabis for extracted oils […]

Read More

Dixie Brands’ board loses two Auxly marijuana executives

Two top executives at the Canadian-based Auxly Cannabis Group resigned from the board of Dixie Brands, a Denver-based maker of cannabis-infused products. Hugo Alves, the president of Auxly, and Michael Lickver, senior vice president of strategy for the Vancouver, British Columbia-based cannabis company, announced their resignations Monday. No reason for their departures was given in a Dixie […]

Read More

British tobacco giant invests CA$123 million in Canadian cannabis firm Auxly

Imperial Brands said it will invest 123 million Canadian dollars ($93.4 million) in a British Columbia cannabis company, the United Kingdom tobacco giant’s latest foray into the marijuana industry. With the investment, Imperial is taking a 19.9% stake in Auxly Cannabis Group, an international cannabis company based in Vancouver, British Columbia. The two companies also […]

Read More

GW Pharma’s cannabis drug OK’d by European Medicines Agency panel

GW Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex. The CHMP is responsible for preparing the European Medicines Agency (EMA)’s opinions on questions related to the marketing of human medicines. The CHMP opinion was adopted July 25, and the final decision now rests […]

Read More

South Korean medical cannabinoid imports surpass 300 units since law passed

South Korea saw just over 300 approved imports of cannabinoid-based medicines in the first few months of the country’s newly regulated medical cannabis program, a volume that underwhelmed local experts who expected demand to be much higher. Almost all the medical cannabis prescriptions were for pure CBD oil. Through July 19, exactly 300 prescriptions had been […]

Read More

Canadian marijuana firm Sundial, California’s KushCo seek Nasdaq listings

Sundial Growers, a Canadian cannabis company, and California-based KushCo Holdings have applied to be listed on the Nasdaq. Sundial, based in Calgary, Alberta, would operate under the ticker symbol SNDL. The number of shares to be offered and the price range for the offering have not been determined. The company currently operates two facilities in its […]

Read More

Billionaire-backed Chinese firm plans Asia’s first e-commerce CBD platform

A company backed by United Kingdom billionaire Jim Mellon and Nuuvera co-founder Lorne Abony plans to establish what they say will be Asia’s first e-commerce platform focusing on CBD-infused products. The pair are part of a group of investors in Hong Kong-headquartered Regent Pacific that is closing in on a $15 million all-stock takeover of […]

Read More

Epidiolex, Sativex maker GW Pharmaceuticals reports Q1 revenue, loss improvement

United Kingdom-based GW Pharmaceuticals showed revenue of $39.2 million for the quarter ended March 31, 2019, compared with $3 million in the same period a year ago. The maker of cannabis-derived medications, including Sativex and Epidiolex, recorded a net loss for the quarter of $50.1 million compared with a year-ago net loss of $69.5 million. […]

Read More

Cover Story: What’s Next for Infused Products

Shaking up your cannabis-infused product line is one way to appeal to new consumers and excite loyal brand enthusiasts. But where do you start? Consistently dosed, cannabis-infused food and beverage products with inventive flavor profiles will continue to win with consumers, manufacturers agree. But leveraging emerging science and technology—and tracking trends in the mainstream food […]

Read More